Page 2 - Glaxosmithkline Pharmaceuticals

From Celin to Septran, GSK Pharma sold 8-10 tail-end brands in FY19

The firm's FY19 annual report shows that it fetched Rs 5 crore during the year from the sale of brands

GlaxoSmithKline, Pfizer to combine consumer health businesses in JV

GSK said on Wednesday the deal laid the foundation for the creation of two new UK-based global companies focused on Pharmaceuticals/Vaccines and Consumer Healthcare

GSK Pharma to pare brands to 20 in India, bring new products into country

The company will launch brand extensions whenever needed and focus on bringing in patented product

GlaxoSmithKline Pharmaceuticals zooms 17% on 1:1 bonus

The stock surged 17% to Rs 3,249, also its 52-week high on the BSE, after its board recommended a bonus issue in the ratio of 1:1.

Cloud over GlaxoSmithKline deal affects outlook; stock down by 8.3%

Final value of transaction hinges on whether distribution arrangement is part of deal

GSK in pole position for Pfizer unit as Reckitt Benckiser quits auction

It is possible Pfizer may receive more offers, the sources added, or it could decide against a sale

GlaxoSmithKline, Reckitt Benckiser in final lap for Pfizer Inc's unit

Glaxo CEO Emma Walmsley said last month that the company's top priority is the pharmaceutical business

GlaxoSmithKline sets up first team for acquisitions in 93 years

As govt increasing price control over branded generic medicines has affected its profitability

GSK hires ex-Walmart executive to boost tech operations, digital platforms

Major drugmakers are grappling with the impact of technology on their businesses

GSK puts old antibiotics and UK Horlicks biz on the block

GSK is also exploring options to divest some other smaller non-core nutrition brands

GlaxoSmithKline Pharma Q3 profit dips 33 per cent at Rs 53 crore

The company had posted a net profit of Rs 78.93 crore for the same period of previous financial year

Pricing pressure in US will continue: CEO GlaxoSmithKline Plc

British drug maker GSK's global CEO Sir Andrew Witty will step down next March after eight years

Access to medicines a problem in India: Annaswamy Vaideesh, GSK India MD

Vaideesh says that the real problem is not capping of drug prices, but in the method adopted in revising prices

GlaxoSmithKline picks insider Emma Walmsley as new CEO

Her appointment is likely to be seen as a signal that GSK will retain the consumer business as a core part of its operations

GSK sells anaesthetics to Aspen for up to $370 million

Aspen is also acquiring rights to the remaining GSK thrombosis drug portfolio

GSK Pharma Q1 net down 23% at Rs 72.27 crore

Shares of the company closed 0.89% down at Rs 3,347.50 per scrip on BSE

GSK Consumer Healthcare slips after weak Q4 earnings

Opening on a weak note, the stocks further slumped 5% to Rs 5,792.

GSK Pharma to launch more combination vaccines

Combination vaccines are becoming popular as their use reduces risk of infection as well as the number of injections to be administered